APR 28, 2020 8:37 AM PDT

Is a multi-cancer detection blood test safe for women?

Earlier detection is essential in order to reduce deaths caused by cancer. A new study, DETECT-A (Detecting cancers Earlier Through Elective mutation-based blood Collection and Testing), has been published recently in the journal Science. Researchers conducting the study have developed a blood test called CancerSEEK that is capable of detecting eight common types of cancer with non-invasive methods. While the new blood test is not meant to replace other methods of early detection,  it is hoped that it will aid in improving detection among particular cancers that are difficult to detect, like ovarian cancer. 

The researchers caution that the study was not conducted with regulatory approval of a specific test in mind. Furthermore, they comment that larger formal trials will be imperative to determine the clinical validity and utility of CancerSEEK as a detection method. 

The study included women with no history of cancer, ages 65 to 75. Lead researcher, Anne Marie Lennon and her colleagues analyzed circulating DNA and protein biomarkers of cancer in the blood of the participating women. The researchers applied the CancerSEEK test to 1005 patients with nonmetastatic, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast and found that the tests were positive in a median of 70% of the eight cancer types.

They found that some cancers were detected by blood analysis, while others were detected by other traditional detection means, like a full-body diagnostic positron emission tomography-computed tomography (PET-CT) scan. Over the 12-month study, 96 cancers were diagnosed in total. Twenty-six of these were detected by the blood test, 24 by standard screening, and 46 by other means. They write in their study: 

“The sensitivities ranged from 69 to 98% for the detection of five cancer types (ovary, liver, stomach, pancreas, and esophagus) for which there are no screening tests available for average-risk individuals. The specificity of CancerSEEK was greater than 99%: only 7 of 812 healthy controls scored positive. In addition, CancerSEEK localized the cancer to a small number of anatomic sites in a median of 83% of the patients.”

Photo: Pixabay

Another important follow-up conclusion from the study shows that women who underwent blood test detection did not significantly change their habits in regards to receiving other forms of detection screening. According to Eureka Alert, the fact that the women in the study did not have fewer mammograms after the baseline blood test than they had in the years prior suggests that such a test “can be incorporated into routine clinical care and not discourage participants from engaging in standard-of-care screening, which the authors emphasize their approach shouldn't replace.” 

Sources: Science, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 11, 2020
Cancer
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
SEP 11, 2020
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
Chemotherapy is a life-saving discovery for cancer patients. One of its biggest drawbacks is the toxicity that comes wit ...
OCT 05, 2020
Cancer
Does Having an Appendectomy Increase Your Risk for Cancer?
OCT 05, 2020
Does Having an Appendectomy Increase Your Risk for Cancer?
Cancer research is more than just the study of diagnostics and novel therapies. Researchers also investigate the causes ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 11, 2020
Cancer
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
NOV 11, 2020
A New CDK Inhibitor Could Help with Unresponsive Liver Cancer
Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDK ...
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
Loading Comments...